A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sibutramine
Bunaftine
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Bunaftine.
Sibutramine
Nizofenone
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Nizofenone.
Sibutramine
Otilonium
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Otilonium.
Sibutramine
Oxatomide
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Oxatomide.
Sibutramine
Abexinostat
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Abexinostat.
Sibutramine
Mizolastine
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Mizolastine.
Sibutramine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Ricolinostat.
Sibutramine
Simendan
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Simendan.
Sibutramine
CUDC-101
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with CUDC-101.
Sibutramine
Entinostat
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Entinostat.
Sibutramine
Mocetinostat
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Mocetinostat.
Sibutramine
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Dexchlorpheniramine maleate.
Sibutramine
Benidipine
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Benidipine.
Sibutramine
Ceritinib
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Ceritinib.
Sibutramine
Fendiline
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Fendiline.
Sibutramine
Bedaquiline
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Bedaquiline.
Sibutramine
Crizotinib
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Crizotinib.
Sibutramine
Antazoline
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Antazoline.
Sibutramine
Nilvadipine
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Nilvadipine.
Sibutramine
Telavancin
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Telavancin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3